The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market.
The Blood
Screening Market is
projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a
CAGR of 12.8%.
Download
PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042
Market Segmentations:-
Based on product & service, the blood screening market
is segmented into reagents and kits, instruments, and software and services.
The reagents and kits segment accounted for the largest share of the blood
screening market in 2019. The large share of this segment can be attributed to
the high consumption and repeated use of reagents & kits in blood screening
procedures. Also, the accessibility of a wide range of reagents and the need
for reliable, specific, and fast detection of TTIs are driving the growth of
the blood screening reagents & kits market.
Based on end users, the blood screening market is
segmented into blood banks and hospitals. The blood bank segment accounted for
the larger market share in 2019 and is projected to witness a higher growth
rate during the forecast period.
Recent Developments:-
- In September 2019, The US FDA approved cobas
Babesia, Roche’s first whole-blood test for donor screening, in accordance
with May 2019 FDA-updated industry guidance recommending screening and
testing for Babesia.
- In February 2019, Grifols received FDA
approval for the Procleix Babesia Assay for donor screening on its
Procleix Panther System.
- In October 2016, Merck opened a new Life
Science Center in Burlington, Massachusetts, to serve as a regional hub
for scientific advancement and customer collaboration.
Regional Analysis:
Based on region, the blood screening market is segmented
into North America, Europe, the Asia Pacific, Latin America, and the Middle
East and Africa. In 2019, North America accounted for the largest market share,
followed by Europe.
Speak
To Analyst: - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=267747042
Key
Players:-
The prominent players operating in the blood screening
market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott
Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens
Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc.
(US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US),
DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore
(Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US),
and J Mitra & Co. Pvt. Ltd (India).
No comments:
Post a Comment